Program

Thursday February 20, 2014
7:00-8:00 AM

Networking breakfast
Office Hours
- Andrew Laster US and Cyrus Cooper UK

Great Hall Central
Council
8:00-9:30 AM

Plenary I: Osteoporosis in the Americas

FRAX® in the Americas
Eugene McCloskey UK

Fracture Risk Assessment, Osteoporosis Treatments and Specific Challenges in North America
Neil Binkley US

Fracture Risk Assessment, Osteoporosis Treatments and Specific Challenges in Latin America
Patricia Clark MX

Great Hall North
9:30-10:00 AM Break Great Hall Central
10:00-11:00 AM Concurrent Sessions
For Clinicians:

  • Best Bone Papers in 2013
    Nelson Watts US
  • Glucocorticoid-induced Osteoporosis Guidelines
    René Rizzoli CH
Great Hall North
  For Technologists:
  • Evaluation of Challenging DXA Cases – What a Technologist Should Do?
    Bruno Muzzi Camargos BR
Great Hall East & West
11:00-11:30 AM Break Great Hall Central
11:30 AM-12:30 PM Concurrent Sessions
For Clinicians:
  • What's new in Skeletal Assessment and Failure Prediction?
    Mary Bouxsein US
  • Stump the Expert, Presentation of Clinical DXA Cases
    Harold Rosen US
Great Hall North
  For Technologists:
  • FRAX®: How a Technologist Can Generate Accurate Fracture Risk Assessment
    Susan vander Kamp IE
Great Hall East & West
12:30-1:00 PM Break Great Hall Central
1:00-2:00 PM Meet-The-Experts  
  Glucocorticoid-induced Osteoporosis: A case-based discussion on diagnosis and management
Cristiano Zerbini BR
Great Hall North
  Clinical Conundrums: A discussion of challenging disease management
Paul Miller US
Great Hall East & West
  Case-Based DXA Interpretation for Clinicians
Joao Borges BR
Knights Hall
 

Clinical Conditions Associated with Osteoporosis and its Treatment: What a Technologist should know
Fergus McKiernan US

Senate
  Office hours - E.Michael Lewiecki US and Marius Kraenzlin CH Council
  Editorial Board Meeting for Journal of Clinical Densitometry Westminster
2:00-3:00 PM Concurrent Sessions
For Technologists:

  • Vertebral Fracture Assessment by DXA, Technical Acquisition and Analysis
    Lawrence Jankowski US
Great Hall East & West
  Abstract Poster Session Great Hall Central
3:00-4:00 PM Plenary II: Epidemiology and Biomechanics
  • Trends in Fracture Incidence, Osteoporosis Diagnosis and Treatment
    Cyrus Cooper UK
  • Biomechanics and Skeletal Health Assessment
    Angela Cheung CA
Great Hall North
4:00-4:30 PM Break Great Hall Central
4:30-5:30 PM Concurrent Sessions
For Clinicians:
  • Use of Biochemical Markers of Bone Turnover in Clinical Practice
    Paul Miller US
  • Treat to Target for Osteoporosis
    Eugene McCloskey UK
Great Hall North
  For Technologists:
  • Precision and Cross Calibration Assessments, Why, When and How?
    Anita Colquhoun CA
Great Hall East & West
5:30 PM Welcome Reception Great Hall Central
Friday February 21, 2014
7:00-8:30 AM ISCD Business Meeting Great Hall Central
  IOF Latin America Regional Advisory Council By invitation only Gallery
7:30-8:30 AM Networking breakfast Great Hall Central
8:30-9:30 AM Meet-The-Experts
  • Glucocorticoid-induced Osteoporosis: A case-based discussion on diagnosis and management
    Cristiano Zerbini BR
Great Hall North
 
  • Clinical Conundrums: A discussion of challenging disease management
    Paul Miller US
Great Hall East & West
 
  • Case-Based DXA Interpretation for Clinicians
    Joao Borges BR
Knights Hall
 
  • Clinical Conditions Associated with Osteoporosis and its Treatment: What a Technologist should know
    Fergus McKiernan US
Senate
9:30-10:30 AM Concurrent Sessions
For Clinicians:

  • Oral abstract presentations
Great Hall North
  For Technologists:
  • Hologic Software Applications and Features, a Case-Based Demonstration
    Kate Queen US & Sharon Wartenbee US
Great Hall East & West
10:30-11:00 AM Break Great Hall Central

11:00AM-12:00 PM

Concurrent Sessions
For Clinicians:

  • Non-Pharmacological Skeletal Therapeutics: Vitamin D, nutrition and exercise
    Bess Dawson-Hughes US
  • Sarcopenia: Defining a disease and why it is important
    René Rizzoli CH
Great Hall North
 

For Technologists:

  • GE Software Application and Features, a Case-Based Demonstration
    William Leslie CA & Joann Caudill US

Great Hall East & West

 

12:00-12:30 PM Break Great Hall Central

12:00-1:00 PM

 

Office hours - Harold Rosen US and Bess Dawson-Hughes US

 

Council
12:30-1:30 PM

Meet-The-Experts

  • Obesity and Fracture: The crosstalk between fat and bone
    Juliet Compston UK
Great Hall North
 
  • Selecting the Appropriate Therapy to Treat Low Bone Mass
    Marius Kraenzlin CH
Great Hall East & West
 
  • Interpreting Body Composition in the Clinical Setting
    Neil Binkley US
Knights Hall
 
  • Selected DXA Publications from 2013
    Diane Krueger US
Senate
  ISCD Corporate Advisory Council Meeting
(by invitation only)
Westminster
1:30-2:30 PM

Concurrent Sessions
For Technologists:

  • Body Composition Analysis
    Lisa King US
Great Hall East & West
  Abstract Poster Session Great Hall Central
2:30-4:00 PM Concurrent Sessions  
  A Case-based Application of the New 2013 ISCD Official Positions
  • Revised Official Positions
    John Schousboe US
  • Revised Body Composition Official Positions
    John Sheperd US
  • Revised Pediatric Official Positions
    Catherine Gordon US
Great Hall North
  Secondary Fracture Prevention: Where we are
  • Capture the Fracture, a Worldwide Initiative to Prevent the Second Fracture
    Cyrus Cooper UK
  • North American Trends in Fracture Prevention
    Robert Adler US
  • Latin America Fracture Liaison Service
    Patricia Clark MX
Great Hall East & West
4:00-4:30 PM Break Great Hall Central
4:30-5:30 PM

Concurrent Sessions
For Clinicians:

  • IOF-ISCD Young Investigator Awards
  • Oral Abstract Presentations
Great Hall North
  For Technologists:
  • DXA Scans for Clinical Practice, What Interpreters Need from Technologists
    Christopher Shuhart US
Great Hall East & West
Saturday February 22, 2014
7:30-8:30 AM

Regional Panels:

 
  United States
Co-chair: Andrew Laster US & Bess Dawson-Hughes US
Great Hall North
  Canada
Co-chairs: William Leslie CA & Angela Cheung CA
Senate
 

Asia-Pacific
Co-chairs: Paulo Chih-Hsing Wu TWN & Cyrus Cooper UK

Knights Hall
 

Iberian American
Co-chairs: Bruno Muzzi Camargos BR & Osvaldo Messino AR

Great Hall East & West
 

Europe-Middle East & Africa
Co-chairs: Juliet Compston UK & John Carey IE

Cloister
  Office hours - Paul Miller US and Eugene McCloskey UK Council
  Networking breakfast Great Hall Assembly
8:30-9:30 AM Meet-The-Experts  
 
  • Obesity and Fracture: The crosstalk between fat and bone
    Juliet Compston UK
Great Hall North
 
  • Selecting the Appropriate Therapy to Treat Low Bone Mass
    Marius Kraenzlin CH
Great Hall East & West
 
  • Interpreting Body Composition in the Clinical Setting
    Neil Binkley US
Knights Hall
 
  • Selected DXA Publications from 2013
    Diane Krueger US
Senate
9:30-10:30 AM

Concurrent Sessions
For Clinicians:

  • What’s New Regarding ONJ and Atypical Femur Fracture: How to communicate the real risk to your patients?
    Angela Cheung CA
  • Drug Holidays: Myth, reality and uncertainty
    E Michael Lewiecki US
Great Hall North
  For Technologists:
  • DXA Reimubrsement: How to overcome challenges and the impact of the ICD-10 coding system
    Anita Henderson-Sumpter US
Great Hall East & West
10:30-11:00 AM Break Great Hall Assembly
11:00 AM-12:00 PM Plenary III - New treatments and tools for osteoporosis
  • Novel and Emerging Treatments for Osteoporosis
    John Bilezikian US
  • Vertebral Fracture Assessment in Clinical Care, an Underutilized Tool
    John Schousboe US
Great Hall North

The meeting agenda will be comprised of:

Plenary topics

Osteoporosis in the Americas:

  • FRAX® in the Americas
  • Fracture Risk Assessment, Osteoporosis Treatments and Specific Changes in North America
  • Fracture Risk Assessment, Osteoporosis Treatments and Specific Changes in Latin America

Epidemiology and Biomechanics:

  • Trends in osteoporosis and fracture/incidence
  • Biomechanic and Skeletal Health Assessment

Skeletal Assessment:

  • What's New in Skeletal Health Assessment and Fracture Prediction?
  • Vertebral Fracture Assessment in Clinical Care, an Underutilized Tool

Meet-the-Experts

Glucocorticoid-induced Osteoporosis: A Case-based Discussion on Diagnosis and Management
Clinical Conundrums: A Discussion of Challenging Disease Management
Case-based DXA Interpretation for Clinicians
Selected DXA Publications from 2013
Obesity and Fracture: The Crosstalk between Fat and Bone
Selecting the Appropriate Therapy to Treat Osteoporosis
Interpreting Body Composition in the Clinical Settling
Clinical Conditions Associated with Osteoporosis and Its Treatment, What a Technologist Should Know

Concurrent Session Topics

Best Bone Papers in 2013
Glucocorticoid-induced Osteoporosis Guidelines
Stump the Expert:  Presentation of Clinical DXA Cases
Novel & Emerging Treatments for Fracture
DXA and Fracture Risk Assessment Tools
Use of Biochemical Markers of Bone Turnover in Clinical Practice
Treat to Target for Osteoporosis
Non-Pharmacological Skeletal Therapeutics: Vitamin D, Nutrition and Exercise
Sarcopenia:  Defining a Disease and Why It's Important
What’s New Regarding ONJ and Atypical Fractures: How to Communicate the Real Risk to Your Patients?
Drug Holidays: Myth, Reality, and Uncertainty
Secondary Fracture Prevention: Where We Are
     - Capture the Fracture, a Worldwide Initiative to Prevent a Second Fracture
     - North American Trends in Fracture Prevention
     - Latin America Fracture Liaison Service
ISCD Official Positions:  A Case-Based Application of the New 2013 Positions
ISCD Body Composition Positions:  A Case-Based Application of 2013 Positions
ISCD Pediatric Positions:  A Case-Based Application of the 2013 Positions
Evaluation of Challenging DXA Cases, What a Technologist Should Do
FRAX®, How a Technologist Can Generate Accurate Fracture Risk Assessment
Vertebral Fracture Assessment by DXA, Technical Acquisition and Analysis
Precision and Cross-Calibration Assessments, Why, When and How?
Hologic Software Applications and Features, a Case-Based Demonstration
GE Software Applications and Features, a Case-Based Demonstration
Body Composition Analysis for Technologists
DXA Scans for Clinical Practice, What Interpreters Need from Technologists

Regional Panels/Discussions

Five concurrent regional panels will address relevant hot topics for North America, Latin America, Canada, Europe, and Asia Pacific.

Office Hours

Bring your challenging cases to our experts! Our expert Clinicians will advise on clinically related issues and on patient specific cases. You may bring scans for review.

Poster Sessions

Poster viewing sessions will be held on Thursday, February 20 - 2:00 -3:00 PM and Friday, February 21 –1:30 –2:30 PM.

Oral Presentations

Authors of selected abstracts will present their work during the morning plenary session on Friday, February 21, 2014.

Meeting and Conference Objectives

To provide Clinicians, Technologists and Researchers with state of the art knowledge and skills needed to optimally identify and manage patient care. Specifically, by the end of the program, attendees will be able to:

  1. Analyze the latest emerging treatments available for patients with Osteoporosis
  2. Apply clinical tools and resources to optimize osteoporosis management, with understanding of the latest developments in fracture risk assessment tools, pharmacological and non-pharmacological therapies, and treatment-related issues such as rare serious side effects and drug holidays.
  3. Practice improved communication skills between Technologist and Physician
  4. Understand the techniques involved in obtaining quality bone mass assessments and how poorly obtained measurements and inaccurate interpretation negatively impacts clinical care.
  5. Review and incorporate into practice the revised ISCD Official Positions regarding Pediatrics, Total Body Composition, DXA, Vertebral Fracture and Utilization of Normative Databases
  6. Assess the role of sarcopenia, frailty and body composition in the clinical setting.

CME and CE Information

Credit Designation: ISCD designates this live educational activity for up to 17.5 AMA PRA Category 1 Credit(s)™. Physicians should only claim credits commensurate with the extent of their participation in the activity.

Accreditation Statement: ISCD is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to offer continuing medical education for physicians.

CE Credit: ISCD and IOF are applying to the ASRT for Category A continuing education credits. Technologists will need to check in and out of every session to verify attendance and receive credit. Partial credit will not be given to any session. 

For physicians assistants: The American Academy of Physician Assistants (AAPA) accepts Category 1 CME Credit™ for the PRA from organizations accredited by the Accreditation Council for Continuing Education (ACCME). ISCD is an accreditated provider through the ACCME.

Through an agreement between the American Medical Association and the European Union of Medical Specialists, physicians may convert AMA PRA Category 1 Credits™ to an equivalent number of EACCME credits. Information on the process to convert AMA credit to EACCME credit can be found at www.ama-assn.org/go/internationalcme or contact accreditation@uems.net.